Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Haas

Showing results (411-420 of 542) with videos related to

Pageof 55
Sort By:
AIDS (London, England)|December 4, 2004
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIVConstance A Benson, Charles van der Horst, Anthony Lamarca, et al.
Pharmacogenomics|June 20, 2025
Genetic polymorphisms and adverse reactions to antituberculosis therapyHannah M Gunter, Phuti Choshi, Tafadzwa Chimbetete, et al.
AIDS and Behavior|September 9, 2020
The Effects of Perceived Stress and Cortisol Concentration on Antiretroviral Adherence When Mediated by Psychological Flexibility Among Southern Black Men Living with HIVRobert L Cooper, Lauren L Brown, Mohammad Tabatabai, et al.
AIDS Research and Human Retroviruses|July 4, 2018
Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral TherapyAsha R Kallianpur, Mariana Gerschenson, Todd Hulgan, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2000
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia GroupJ Fagon, H Patrick, D W Haas, et al.
AIDS (London, England)|December 29, 2004
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group studyDavid W Haas, Heather J Ribaudo, Richard B Kim, et al.
The Journal of Infectious Diseases|January 3, 2001
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trialD W Haas, W J Fessel, R A Delapenha, et al.
Antiviral Therapy|August 9, 2001
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adultsD McMahon, M Lederman, D W Haas, et al.
AIDS (London, England)|November 2, 2013
Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotypeHelen M McIlleron, Michael Schomaker, Yuan Ren, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Pageof 55

Showing results (411-420 of 542) with videos related to

Sort By:
Pageof 55
AIDS (London, England)|December 4, 2004
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIVConstance A Benson, Charles van der Horst, Anthony Lamarca, et al.
Pharmacogenomics|June 20, 2025
Genetic polymorphisms and adverse reactions to antituberculosis therapyHannah M Gunter, Phuti Choshi, Tafadzwa Chimbetete, et al.
AIDS and Behavior|September 9, 2020
The Effects of Perceived Stress and Cortisol Concentration on Antiretroviral Adherence When Mediated by Psychological Flexibility Among Southern Black Men Living with HIVRobert L Cooper, Lauren L Brown, Mohammad Tabatabai, et al.
AIDS Research and Human Retroviruses|July 4, 2018
Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral TherapyAsha R Kallianpur, Mariana Gerschenson, Todd Hulgan, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2000
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia GroupJ Fagon, H Patrick, D W Haas, et al.
AIDS (London, England)|December 29, 2004
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group studyDavid W Haas, Heather J Ribaudo, Richard B Kim, et al.
The Journal of Infectious Diseases|January 3, 2001
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trialD W Haas, W J Fessel, R A Delapenha, et al.
Antiviral Therapy|August 9, 2001
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adultsD McMahon, M Lederman, D W Haas, et al.
AIDS (London, England)|November 2, 2013
Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotypeHelen M McIlleron, Michael Schomaker, Yuan Ren, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Pageof 55